Alessandro Granito
0000-0002-0637-739X
Publication & Citation Trends
Most Cited Works
Publications
270 total
Regorafenib use in patients with unresectable hepatocellular carcinoma: analyses of subgroups of special interest in the observational REFINE study
Cited by 0
Semantic Scholar
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis
Cited by 2
Semantic Scholar
Neutrophil–lymphocyte ratio is associated with worse outcomes in patients with cirrhosis: insights from the PRO-LIVER Registry
Cited by 2
Semantic Scholar
From thrombosis to transplantation: The role of anti-phospholipid antibodies in liver disease management
Cited by 3
Semantic Scholar
Pure red cell aplasia due to Parvovirus B19 infection and atezolizumab: case report and literature review.
Cited by 2
Semantic Scholar
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-Bevacizumab
Cited by 3
Semantic Scholar
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study.
Cited by 3
Semantic Scholar
964P Lenvatinib (L) and sorafenib (S) in patients (pts) with advanced or unresectable hepatocellular carcinoma (uHCC): An international, multicenter, phase IV study (STELLAR)
Cited by 0
Semantic Scholar
Research Topics
Hepatocellular Carcinoma Treatment and Prognosis
(118)
Liver Disease Diagnosis and Treatment
(101)
Liver Diseases and Immunity
(60)
Celiac Disease Research and Management
(42)
Colorectal Cancer Treatments and Studies
(30)
Frequent Co-Authors
Affiliations
University of Padua
GTx (United States)
University of Milan
The Royal Free Hospital
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola